A detailed history of Pnc Financial Services Group, Inc. transactions in Dare Bioscience, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 4,400 shares of DARE stock, worth $1,496. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,400
Previous 4,400 -0.0%
Holding current value
$1,496
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$1.04 - $1.27 $1,040 - $1,270
1,000 Added 29.41%
4,400 $0
Q2 2022

Aug 12, 2022

BUY
$0.94 - $1.76 $940 - $1,760
1,000 Added 41.67%
3,400 $4,000
Q4 2021

Feb 11, 2022

BUY
$1.42 - $2.13 $1,420 - $2,130
1,000 Added 71.43%
2,400 $4,000
Q3 2021

Nov 05, 2021

BUY
$1.42 - $2.0 $1,988 - $2,800
1,400 New
1,400 $2,000
Q2 2018

Aug 10, 2018

SELL
$0.76 - $1.48 $38 - $74
-50 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$0.83 - $2.79 $41 - $139
50 New
50 $0

Others Institutions Holding DARE

About Dare Bioscience, Inc.


  • Ticker DARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,820,896
  • Market Cap $28.8M
  • Description
  • Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...
More about DARE
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.